NCT05523856Active, not recruiting
New Treatment Modalities for Localized Prostate Cancer
Comparative Effectiveness of New Treatment Modalities for Localized Prostate Cancer
Source: ClinicalTrials.gov · Last updated 12 Mar 2025
Brief summary (registry, in English)
The purpose of this study is to evaluate the effectiveness of four of the nowadays most established primary treatments for patients with clinically localized prostate cancer (active surveillance, robot-assisted radical prostatectomy, intensity-modulated radiotherapy, and real-time brachytherapy) at short-, mid- and long-term follow-up. The primary aim is assessing the impact of treatments' side effects on patient's quality of life. As secondary objectives, biochemical disease-free survival, overall survival, and prostate cancer-specific survival will also be assessed.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 480 (actual)
- First submitted
- 26 Jul 2022
- Start date
- Apr 2014
- Primary completion date
- Apr 2014
- Lead sponsor
- Fundacion IMIM
- Diseases
- Prostate cancer
- NCT number
- NCT05523856
What you commit to
- Study type: Observational
- Participants enrolled: 480
- From Apr 2014 to the primary completion date, Apr 2014
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous pelvic treatments.
Other
- Body mass index \> 33.
- Neoadjuvant hormonal treatment.
- Presence of serious comorbidities.
Who the study is looking for
- Age between 50 and 75 years.
- Clinical stage T1 or T2, N0/Nx and M0/Mx.
- Gleason ≤6 or 7 (if 3+4 with T1c).
- Prostate-Specific Antigen (PSA) ≤ 10 .
- To be treated with active surveillance, robot-assisted radical prostatectomy, intensity-modulated radiotherapy or real-time brachytherapy
Age in the registry: 50 years to 75 years · Sex: Male · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.